Hochhaus A - Search Results

1

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J, Baccarani M, Cortes J, Cross NC, Druker BJ, Gabert J, Grimwade D, Hehlmann R, Kamel-Reid S, Lipton JH, Longtine J, Martinelli G, Saglio G, Soverini S, Stock W, Goldman JM. Hughes T, et al. Among authors: hochhaus a. Blood. 2006 Jul 1;108(1):28-37. doi: 10.1182/blood-2006-01-0092. Epub 2006 Mar 7. Blood. 2006. PMID: 16522812 Free PMC article. Review.

2

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Br J Haematol. 1995 Sep;91(1):126-31. doi: 10.1111/j.1365-2141.1995.tb05257.x. Br J Haematol. 1995. PMID: 7577619

3

New perspectives with interferon alpha. The German CML study group experience.

Hehlmann R, Ansari H, Adelberger V, Heinze B, Hossfeld K, Hochhaus A, Heimpel H. Hehlmann R, et al. Among authors: hochhaus a. Bone Marrow Transplant. 1994;14 Suppl 3:S14-20. Bone Marrow Transplant. 1994. PMID: 7697004 Review. No abstract available.

4

Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.

van Rhee F, Marks DI, Lin F, Szydlo RM, Hochhaus A, Treleaven J, Delord C, Cross NC, Goldman JM. van Rhee F, et al. Among authors: hochhaus a. Leukemia. 1995 Feb;9(2):329-35. Leukemia. 1995. PMID: 7869772

5

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, et al. Hehlmann R, et al. Among authors: hochhaus a. Blood. 1994 Dec 15;84(12):4064-77. Blood. 1994. PMID: 7994025 Free article. Clinical Trial.

6

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Blood. 1996 Feb 15;87(4):1549-55. Blood. 1996. PMID: 8608246 Free article.

7

Mutational analysis of the p15 and p16 genes in acute leukaemias.

Sill H, Aguiar RC, Schmidt H, Hochhaus A, Goldman JM, Cross NC. Sill H, et al. Among authors: hochhaus a. Br J Haematol. 1996 Mar;92(3):681-3. doi: 10.1046/j.1365-2141.1996.340858.x. Br J Haematol. 1996. PMID: 8616035

8

Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.

Melo JV, Hochhaus A, Yan XH, Goldman JM. Melo JV, et al. Among authors: hochhaus a. Br J Haematol. 1996 Mar;92(3):684-6. doi: 10.1046/j.1365-2141.1996.00350.x. Br J Haematol. 1996. PMID: 8616036

9

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC. van Rhee F, et al. Among authors: hochhaus a. Blood. 1996 Jun 15;87(12):5213-7. Blood. 1996. PMID: 8652835 Free article.

10

Expression of the LH2 gene in chronic myeloid leukaemia cells.

Al-Jehani F, Hochhaus A, Spencer A, Goldman JM, Melo JV. Al-Jehani F, et al. Among authors: hochhaus a. Leukemia. 1996 Jul;10(7):1122-6. Leukemia. 1996. PMID: 8683990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters